Walden Biosciences takes in $51m Series A
Cambridge, Massachusetts-based Walden Biosciences Inc, a biotech company focused on treating kidney disease, has raised $51 million in Series A financing.
6 October 2020•1 min read
Cambridge, Massachusetts-based Walden Biosciences Inc, a biotech company focused on treating kidney disease, has raised $51 million in Series A financing.
New AI threats are fueling VC investment in cybersecurity
22 October 2026 · 4 mins read
Inspired Capital holds quick close on $450m for Fund IV
20 October 2026 · 4 mins read
Inovia hits $200m in first close for sixth early-stage fund
19 October 2026 · 4 mins read
San Joaquin County to slow venture commitments
15 October 2026 · 2 mins read
DOWNLOAD: Fundraising holds steady in Q3
14 October 2026 · 2 mins read
Why Endeavor Catalyst is betting big on Southeast Asia
8 October 2026 · 4 mins read
Dig's new fund bets on infrastructure built around foundation models
6 October 2026 · 4 mins read
